Get the SPI Wire

LIFEVANTAGE CORPORATION

NASDAQ:LFVN
Annual Meeting

of Shareholders

MEETING DATE

11/05/2026
DEF 14A FILED
09/18/2026
PUBLISHED
09/18/2026 8:05 pm
TIME TO PUBLISH
09/20/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:LFVN · CUSIP 53222K205 · CLASS common stock · CIK 0000849146

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

3
FOR
0
AGAINST
0
WITHHOLD
3
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
Election of Directors
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states the Board unanimously recommends electing each of the six nominees.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
Advisory Vote as to Our Executive Compensation
compensation
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Greater than 96% of stockholders' votes supported executive compensation at the fiscal year 2026 annual meeting.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
Ratification of Selection of Independent Registered Public Accounting Firm
auditor
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The audit committee concluded Deloitte is independent of the Company and management.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

85924ed52d5afeb4fd724b03c9c35d220b1e7f228d4734267e34492e049406ae

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates